Señales en vivo de CEMI | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 abr 2023 @ 16:00):

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases...

Stats
Volumen de hoy	351 642
Volumen promedio	538 392
Capitalización de mercado	16.71M
EPS	$0 ( 2024-03-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.632
ATR14	$0.0250 (5.49%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-11	Angelico Paul	Buy	29 333	Common Stock
2023-03-15	Angelico Paul	Buy	7 885	Common Stock
2023-03-15	Angelico Paul	Sell	2 843	Common Stock
2023-03-11	Angelico Paul	Sell	10 575	Common Stock
2023-03-11	Angelico Paul	Sell	29 333	Restricted stock units

INSIDER POWER
-90.31
Last 100 transactions
Buy: 781 277 \| Sell: 10 790 554

Volumen Correlación

Largo: 0.06 (neutral)

Corto: 0.14 (neutral)

Signal:(58.078) Neutral

Chembio Diagnostics Inc Correlación

10 Correlaciones Más Positivas
EWCZ	0.948
FTDR	0.94
NPCE	0.938
HEWG	0.937
DXGE	0.932
ULTA	0.931
ROBT	0.916
GLBE	0.916
NRC	0.912
WYNN	0.91

10 Correlaciones Más Negativas
ADXN	-0.922
MNSB	-0.912
PRSO	-0.912
GLBS	-0.91
WALD	-0.908
PLL	-0.906
VNET	-0.904
STRS	-0.903
SIFY	-0.902
KBWY	-0.9

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chembio Diagnostics Inc Correlación - Moneda/Commodity

0.64
( weak )

0.62
( weak )

0.00
( neutral )

0.33
( neutral )

-0.67
( moderate negative )

Chembio Diagnostics Inc Finanzas

Annual	2022
Ingresos:	$48.34M
Beneficio Bruto:	$9.76M (20.19 %)
EPS:	$-0.960

FY	2022
Ingresos:	$48.34M
Beneficio Bruto:	$9.76M (20.19 %)
EPS:	$-0.960

FY	2021
Ingresos:	$47.82M
Beneficio Bruto:	$13.32M (27.86 %)
EPS:	$-1.400

FY	2020
Ingresos:	$30.45M
Beneficio Bruto:	$6.58M (21.60 %)
EPS:	$-1.340

Financial Reports:

No articles found.

Chembio Diagnostics Inc

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.